This paper is in the following e-collection/theme issue:

Digital Health Reviews (1174) Digital Biomarkers and Digital Phenotyping (177) Ubiquitous Health (uHealth) (116) Dementia and Cognitive Decline (419)

Published on in Vol 21, No 8 (2019): August

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/12785, first published .
Current State of Digital Biomarker Technologies for Real-Life, Home-Based Monitoring of Cognitive Function for Mild Cognitive Impairment to Mild Alzheimer Disease and Implications for Clinical Care: Systematic Review

Current State of Digital Biomarker Technologies for Real-Life, Home-Based Monitoring of Cognitive Function for Mild Cognitive Impairment to Mild Alzheimer Disease and Implications for Clinical Care: Systematic Review

Current State of Digital Biomarker Technologies for Real-Life, Home-Based Monitoring of Cognitive Function for Mild Cognitive Impairment to Mild Alzheimer Disease and Implications for Clinical Care: Systematic Review

Authors of this article:

Antoine Piau1, 2 Author Orcid Image ;   Katherine Wild2 Author Orcid Image ;   Nora Mattek2 Author Orcid Image ;   Jeffrey Kaye2 Author Orcid Image
Article Authors Cited by (126) Tweetations (9) Metrics
All Time | Last Month | Last Six Months | Last Year
There are currently no tweets available for this article within the specified range.